The global market for contraceptives is estimated to be worth USD 6.05 billion in the year 2015. This market is expected to reach USD 8.78 billion by the end of 2020. During this period, the market is projected to grow at a CAGR of 7.8%.
Global Contraceptive Drugs and Devices Market - Market Dynamics
The report details several factors driving and restraining the market. Some of these are discussed below.
Contributing to the growth of the contraceptives market globally is the necessity to avoid unwanted pregnancies and their complications. A high percentage of women who are sexually active do not want to become pregnant. This number is as high as 70% in the USA. The need to avoid unwanted pregnancies, especially in teenage women, is one of the major drivers for this market.
It is also observed that more than half of the women identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain, and acne, as reasons for use. These are also some of the factors contributing to the growth of the market. The other factors helping the growth of the contraceptives market are the increasing incidence of STDs and the rapid increase in population. Government initiatives promoting the use of contraceptives to avoid unnecessary births and the health benefits from using the contraceptives have also been important players in the growth of the market.
Factors such as religious and cultural opposition in certain emerging nations have been restraining the growth of this market. Along with this, the fear of certain side effects and issues such as infertility resulting from the use of contraceptives have been major setbacks from the market point of view. Issues such as limited access to contraceptives in the developing and economically backward nations have been another setback in this market. It is estimated that among the global female population, the need for contraceptive prevalence or meeting the needs of family planning is estimated to as high as 16.2%.
The global market for contraceptive drugs and devices can be segmented on the basis of the type of contraceptive method, mode of delivery, device, gender, and geography. On the basis of the type of contraceptive method used, the market is segmented into pills, implants, sterilization, IUDs, injectable, male condoms, vaginal barrier methods, etc. On the basis of the mode of delivery, the market is segmented into oral, topical and contraceptive injectable. On the basis of the device, the market is segmented into condoms, diaphragms, cervical caps, sponges and vaginal rings.
Geographically, North America holds the largest market share. Over 90% of the female population in North America uses the modern contraceptive techniques. The use of contraceptives is the highest in North America, whose share is estimated to be 75.4%. Following North America, Europe is the second largest market globally. The contraceptive prevalence in Europe is estimated to be 70%. The emerging nations have shown an increase in contraceptive prevalence in recent times. However, there is a large population with unmet needs in terms of contraceptive usage. This makes emerging nations a hot destination for the contraceptives market.
This Report Offers:
- Market definition for global contraceptive drugs & devices market along with identification of key drivers and restraints for the market.
- Market analysis for the contraceptives drugs & devices market, with region-specific assessments and competition analysis on a global and regional scale.
- Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
- Extensively researched competitive landscape section with profiles of major companies along with their market share.
- A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
1.1 Study Deliverables
1.2 General Study Assumptions
1.3 Market Definition
2. RESEARCH METHODOLOGY
2.2 Analysis Methodology
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Degree of Competition
5.2.4 Threat of Substitution
5.2.5 Threat of New Entrants
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Growing prevalence of unwanted pregnancies
6.1.2 Government and NGO initiatives to promote contraception
6.1.3 Increasing prevalence of Sexually Transmitted Diseases (STDs)
6.1.4 Implementation of the Patient Protection Act or the Affordable Healthcare Act
6.2 Market Restraints
6.2.1 Side effects associated with the use of contraceptive drugs and devices
6.2.2 Rising prevalence of infertility among women
6.2.3 Ethical and social issues limiting the use of contraceptives in some countries
6.3 Market Opportunities
6.3.1 The contraceptives market in emerging and upcoming markets is mostly untapped
6.3.2 Increasing demand for the development of novel and innovative contraceptives like the male contraceptive pills
6.4 Key Challenges
6.4.1 High failure rate of contraceptives
6.4.2 Lack of awareness about contraception in developing and third world countries
7. GLOBAL CONTRACEPTIVE MARKET - SEGMENTATION
7.1 By Product Type
7.1.1 Contraceptive Drugs
188.8.131.52 Contraceptive Pills
184.108.40.206.1 Hormonal Pills
220.127.116.11.1.1 Combined Oral Contraceptive Pill
18.104.22.168.1.2 Progestin Only Pill
22.214.171.124 Non-Hormonal Pill
126.96.36.199 Contraceptive Injections
188.8.131.52 Topical Contraceptives
7.1.2 Contraceptive Devices
184.108.40.206 Male Contraceptive Devices
220.127.116.11 Male Condoms
18.104.22.168 Female Contraceptive Devices
22.214.171.124.2 Diaphragms & Caps
126.96.36.199.3 Vaginal Rings
188.8.131.52.4 Contraceptive Sponges
184.108.40.206.5 Sub-Dermal Contraceptive Implants
220.127.116.11.6 Intra Uterine Contraceptive Devices (IUCDs)
18.104.22.168.6 Copper IUCDs
22.214.171.124.6 Hormonal IUCDs
126.96.36.199.7 Non-Surgical Permanent Contraception Devices
8. GLOBAL CONTRACEPTIVE MARKET, BY GEOGRAPHY - REGIONAL SHARES AND FORECAST
8.1 North America
8.1.1 United States
8.2.1 United Kingdom
8.2.6 Rest of Europe
8.3.5 South Korea
8.3.6 Rest of Asia-Pacific
8.4 Middle East and Africa
8.4.1 GCC Countries
8.4.3 South Africa
8.4.4 Rest of Middle East and Africa
8.5 South America
8.5.3 Rest of South America
9. COMPETITIVE LANDSCAPE
9.1 Company Share Analysis
9.2 Mergers and Acquisitions Analysis
9.3 New Product Launches
9.4 Agreements, Collaborations & Partnerships
10. COMPANY PROFILES
10.2. Bayer HealthCare AG
10.3. Church & Dwight Co., Inc.
10.4. CooperSurgical, Inc.
10.6. Mayer Laboratories, Inc.
10.7. Merck & Co
10.8. Pfizer, Inc.
10.9. Reckitt Benckiser Plc.
10.10. Teva Pharmaceuticals
10.11. The Female Health Company
10.12. Warner Chilcott Company, Inc.
11. FUTURE OF THE MARKET
12. ANALYST OUTLOOK FOR INVESTMENT OPPORTUNITIES
- Bayer HealthCare AG
- Church & Dwight Co., Inc.
- CooperSurgical, Inc.
- Mayer Laboratories, Inc.
- Merck & Co
- Pfizer, Inc.
- Reckitt Benckiser Plc.
- Teva Pharmaceuticals
- The Female Health Company
- Warner Chilcott Company, Inc.